SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-139116
Filing Date
2024-05-15
Accepted
2024-05-15 11:47:00
Documents
6
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d814423ddef14a.htm DEF 14A 669826
2 GRAPHIC g814423g0423115746058.jpg GRAPHIC 4429
3 GRAPHIC g814423g25d26.jpg GRAPHIC 354835
4 GRAPHIC g814423g26d27.jpg GRAPHIC 331063
5 GRAPHIC g814423g51a24.jpg GRAPHIC 64733
6 GRAPHIC g814423g52b25.jpg GRAPHIC 64152
  Complete submission text file 0001193125-24-139116.txt   1800057
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32001 | Film No.: 24948448
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)